ZURA - Zura Bio Limited
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$15.00
DETAILS
HIGH:
$15.00
LOW:
$15.00
MEDIAN:
$15.00
CONSENSUS:
$15.00
UPSIDE:
180.37%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | |||||
| R&D Expenses | 42.1 | 24.4 | 44.0 | 23.7 | 0 |
| SG&A Expenses | 33.2 | 30.8 | 18.6 | 3.5 | 1.1 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 75.2 | 55.2 | 62.6 | 27.2 | 1.1 |
| Operating Income | |||||
| Operating Income | (75.2) | (55.2) | (62.6) | (27.2) | (1.1) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 6.3 | 8.0 | 2.2 | 0.0 | 0.0 |
| Profitability | |||||
| EBITDA | (68.6) | (52.4) | (60.6) | (27.3) | 8.4 |
| EBIT | (68.7) | (52.4) | (60.6) | (27.3) | 8.4 |
| Income Before Tax | (68.7) | (52.4) | (60.6) | (27.3) | 8.4 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (68.7) | (52.4) | (60.4) | (25.7) | 8.4 |
| Per Share Data | |||||
| EPS (Basic) | -1.06 | -0.60 | -2.09 | 0.21 | 0.40 |
| EPS (Diluted) | -1.06 | -0.60 | -2.09 | 0.21 | 0.40 |
| Shares Outstanding | 94.2 | 75.1 | 33.1 | 17.2 | 17.2 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Current Assets | |||||
| Cash & Cash Equivalents | 109.4 | 176.5 | 99.8 | 1.6 | 0.7 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 2.9 | 2.2 | 1.0 | 0.2 | 0 |
| Total Current Assets | 112.3 | 178.7 | 100.8 | 1.8 | 1.2 |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 0.1 | 0.1 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 139.4 |
| Other Non-Current Assets | 1.5 | 0.7 | 0 | 3.5 | 0 |
| Total Non-Current Assets | 1.6 | 0.8 | 0 | 3.5 | 139.4 |
| Total Assets | 113.9 | 179.5 | 100.8 | 5.3 | 140.6 |
| Current Liabilities | |||||
| Account Payables | 1.3 | 0.7 | 2.7 | 2.0 | 0 |
| Short-Term Debt | 0 | 0 | 0 | 7.8 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.3 | 18.8 | 1.2 | 2.8 | 0.3 |
| Total Current Liabilities | 12.4 | 19.5 | 20.3 | 14.8 | 0.3 |
| Non-Current Liabilities | |||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 1.0 | 12.5 | 10.1 |
| Total Non-Current Liabilities | 0 | 0 | 1.0 | 12.5 | 10.1 |
| Total Liabilities | 12.4 | 19.5 | 21.3 | 27.3 | 10.4 |
| Stockholders' Equity | |||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0 | 139.4 |
| Retained Earnings | (224.5) | (155.9) | (103.5) | (32.1) | (9.2) |
| Accumulated Other Comprehensive Income | 0 | 0 | 0 | 0 | 0 |
| Total Stockholders' Equity | 101.5 | 146.8 | 59.3 | (32.1) | 130.2 |
| Total Liabilities & Equity | 113.9 | 179.5 | 100.8 | 5.3 | 140.6 |
| Debt Metrics | |||||
| Total Debt | 0 | 0 | 0 | 7.8 | 0 |
| Net Debt | (109.4) | (176.5) | (99.8) | 6.2 | (0.7) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | (68.7) | (52.4) | (60.6) | (27.3) | 8.4 |
| Depreciation & Amortization | 0.0 | 0.0 | 0 | 0 | 0 |
| Stock-Based Compensation | 12.3 | 16.8 | 9.7 | 0.3 | 0 |
| Change in Working Capital | (3.6) | 2.3 | 5.1 | 3.5 | (0.2) |
| Other Non-Cash Items | (4.9) | 5.2 | 30.7 | 22.3 | (9.3) |
| Operating Cash Flow | (64.8) | (28.1) | (15.1) | (1.2) | (1.1) |
| Investing Activities | |||||
| Capital Expenditure | (0.1) | (0.1) | (8) | (12) | (0.0) |
| Acquisitions | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | (139.4) |
| Sales/Maturities of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | (5) | 0 | 0 | 0 |
| Investing Cash Flow | (0.1) | (5.1) | (8) | (12) | (139.4) |
| Financing Activities | |||||
| Net Debt Issuance | 0 | 0 | (10) | 7.6 | (0.1) |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (7.4) | 49.1 | 14.9 | (2.8) | 0.5 |
| Financing Cash Flow | (2.2) | 109.8 | 121.3 | 14.8 | 141.2 |
| Cash Position | |||||
| Net Change in Cash | (67.1) | 76.7 | 98.2 | 1.6 | 0.7 |
| Cash at Beginning | 176.5 | 99.8 | 1.6 | 0 | 0 |
| Cash at End | 109.4 | 176.5 | 99.8 | 1.6 | 0.7 |
| Free Cash Flow | (64.9) | (28.2) | (23.1) | (13.2) | (1.1) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Operating Income | (75.2) | (55.2) | (62.6) | (27.2) | (1.1) |
| Net Income | (68.7) | (52.4) | (60.4) | (25.7) | 8.4 |
| EPS (Diluted) | -1.06 | -0.60 | -2.09 | 0.21 | 0.40 |
| Balance Sheet | |||||
| Cash & Equivalents | 109.4 | 176.5 | 99.8 | 1.6 | 0.7 |
| Total Assets | 113.9 | 179.5 | 100.8 | 5.3 | 140.6 |
| Total Debt | 0 | 0 | 0 | 7.8 | 0 |
| Stockholders' Equity | 101.5 | 146.8 | 59.3 | (32.1) | 130.2 |
| Cash Flow | |||||
| Operating Cash Flow | (64.8) | (28.1) | (15.1) | (1.2) | (1.1) |
| Capital Expenditure | (0.1) | (0.1) | (8) | (12) | (0.0) |
| Free Cash Flow | (64.9) | (28.2) | (23.1) | (13.2) | (1.1) |